Injectafer: Who is Susceptible to Receiving Treatment
For most people, iron levels aren’t something we think about much – at least until there is a problem with them. When a person is iron deficient, their doctors may recommend an infusion of a drug called Injectafer. Designed to increase the quality of life for patients with anemia, the pharmaceutical can reverse iron deficiencies. Unfortunately, though, Injectafer has troubling side effects that threaten the lives of those who receive the infusions.
Who is most likely to receive Injectafer, and why? Let’s delve into the subject.
Primarily used to treat those with iron deficiency, Injectafer has long been associated with those who suffer from anemia. When someone has low iron levels, they may suffer extreme fatigue, anxiety, heart palpitations, and headaches, among other symptoms. While iron supplements are available for such patients, not everyone responds well to iron pills. Injectafer is often recommended for such patients with little to no warning given about the possible side effects.
Crohn’s, Inflammatory Bowel, and Other Intestinal Diseases
Those with intestinal diseases like Crohn’s can struggle to absorb iron properly. Because of this challenge, people with Crohn’s Disease often suffer from iron deficiency, too. Even people who have recently had gastric bypass or other intestinal surgeries can develop iron deficiency issues. In fact, anyone with an irritable GI tract may find themselves struggling to get enough iron. To treat these problems, doctors frequently prescribe Injectafer infusions.
Unbeknownst to many patients taking Injectafer, the drug is associated with potentially life-threatening risks. Many people who receive Injectafer infusions experience severe HPP, a phosphorus deficiency that can be deadly. Those with HPP may experience bone fractures, numbness, weakness, and confusion. Left untreated, HPP can lead to respiratory failure, coma, cardiac arrest, seizures, and even death.
Tragically, many people on Injectafer are not warned of the possible side effects of the drug. The company behind Injectager opted not to include warnings about the risk of HPP on the label. Considering the long history and obvious association of the drug and the increased risk of HPP, this choice is downright negligent. It’s why so many people suffering from the impact of Injectafer are opting to take legal action against the pharmaceutical companies behind the drug.
A Consumer’s Right to Safety
Patients deserve to know the risks associated with the medications they are prescribed. If you or someone you care about has developed HPP after receiving Injectafer, you may have grounds for a lawsuit. To learn more about your legal rights and the possible negligence behind Injectafer’s labels, call our office now. We offer free, no risk consultations for anyone curious about their options following Injectafer infusions.